Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 2
1992 1
1993 1
1994 2
1998 1
2001 1
2002 1
2003 3
2004 1
2005 1
2006 4
2007 2
2008 8
2009 10
2010 6
2011 7
2012 8
2013 5
2014 4
2015 7
2016 6
2017 10
2018 15
2019 9
2020 8
2021 11
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: fukutomi a. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y; JASPAC 01 Study Group. Uesaka K, et al. Among authors: fukutomi a. Lancet. 2016 Jul 16;388(10041):248-57. doi: 10.1016/S0140-6736(16)30583-9. Epub 2016 Jun 2. Lancet. 2016. PMID: 27265347 Clinical Trial.
Migrating mirena.
Fukutomi A, De Souza M. Fukutomi A, et al. Emerg Med Australas. 2013 Aug;25(4):373-4. doi: 10.1111/1742-6723.12102. Emerg Med Australas. 2013. PMID: 23911032 No abstract available.
Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma.
Sugiura T, Uesaka K, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Asakura H, Todaka A, Fukutomi A. Sugiura T, et al. Among authors: fukutomi a. Ann Gastroenterol Surg. 2020 May 15;4(4):455-463. doi: 10.1002/ags3.12345. eCollection 2020 Jul. Ann Gastroenterol Surg. 2020. PMID: 32724890 Free PMC article.
Pathways to eating disorder care: A European multicenter study.
Monteleone AM, Barone E, Cascino G, Schmidt U, Gorwood P, Volpe U, Abbate-Daga G, Castellini G, Díaz Marsá M, Favaro A, Fukutomi A, Guillaume S, Minařík P, Pacheco JAS, Panero M, Papežová H, Ricca V, Segura-Garcia C, Scanferla E, Tyszkiewicz-Nwafor M, Fernandez-Aranda F, Voderholzer U, Treasure J, Monteleone P. Monteleone AM, et al. Among authors: fukutomi a. Eur Psychiatry. 2023 Apr 24;66(1):e36. doi: 10.1192/j.eurpsy.2023.23. Eur Psychiatry. 2023. PMID: 37092677 Free PMC article.
Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04).
Sugiura T, Toyama H, Fukutomi A, Asakura H, Takeda Y, Yamamoto K, Hirano S, Satoi S, Matsumoto I, Takahashi S, Morinaga S, Yoshida M, Sakuma Y, Iwamoto H, Shimizu Y, Uesaka K. Sugiura T, et al. Among authors: fukutomi a. J Hepatobiliary Pancreat Sci. 2023 Nov;30(11):1249-1260. doi: 10.1002/jhbp.1353. Epub 2023 Sep 25. J Hepatobiliary Pancreat Sci. 2023. PMID: 37746781 Clinical Trial.
123 results